Evidence for local IgE production to Aspergillus fumigatus in children with cystic fibrosis

T. Eiwegger, M. Gona, P. Fucik, A. Glaser, F. Horak, E. Nachbaur, S. Renner, S. Gruber, R. Crameri, Z. Szepfalusi, T. Frischer (Vienna, Austria; Davos, Switzerland)

Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Session: Cystic fibrosis: understanding a complex disease
Session type: E-Communication Session
Number: 474
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Eiwegger, M. Gona, P. Fucik, A. Glaser, F. Horak, E. Nachbaur, S. Renner, S. Gruber, R. Crameri, Z. Szepfalusi, T. Frischer (Vienna, Austria; Davos, Switzerland). Evidence for local IgE production to Aspergillus fumigatus in children with cystic fibrosis. Eur Respir J 2009; 34: Suppl. 53, 474

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

RIEDEL Thomas - 13.09.2009 14:18
AF specific IgE in serum?
Did you correlate local AF specific IgE with serum AF specific IgE or total serum IgE?
You must Login to comment this presentation.


Related content which might interest you:
Interleukin-10 genotypes and airways colonization by Aspergillus fumigatus in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 403s
Year: 2005

Impact of Aspergillus fumigatus infection on lung function in children with cystic fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Transmission-frequency of Aspergillus fumigatus in cystic fibrosis patients through coughing
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018

IL-10 induced T-cell tolerance to Aspergillus fumigatus and Pseudomonas aeruginosa in cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 8s
Year: 2001

What is the significance of aspergillus fumigatus in BAL in children with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: detection and monitoring of early lung disease
Year: 2011

Parasexual recombination enables Aspergillus fumigatus to persist in cystic fibrosis
Source: ERJ Open Res, 6 (4) 00020-2020; 10.1183/23120541.00020-2020
Year: 2020



Sensitisation to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017



LATE-BREAKING ABSTRACT: Aspergillus fumigatus specific IgE, but not total IgE or A. fumigatus specific IgG is associated with evidence of lung damage in asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015


Allergic bronchopulmonary aspergillosis (ABPA) prevalence in adult cystic fibrosis (CF) patients. Usefulness of recombinant Aspergillus fumigatus IgE (rAsp f) in diagnosis and monitoring treatment
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012

Non-ABPA Aspergillus bronchitis in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017

Diagnostic value of combined sIgG and sIgE of Aspergillus fumigatus in allergic broncho pulmonary aspergillosis and severe asthma with fungal sensitation
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019

Serologic immunoglobulin E responses against Aspergillus and Candida in patients with chronic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 280s
Year: 2005

Biofilm production of Aspergillus fumigatus on bronchial epithelia cells
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008

Peripheral blood eosinophilia and sensitization to Aspergillus fumigatus in adult patients (pts) with non-cystic fibrosis bronchiectasis (B)
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019

Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
Source: Eur Respir Rev, 29 (158) 200011; 10.1183/16000617.0011-2020
Year: 2020



IgE sensitization to Aspergillus fumigatus among children in allergological centre of Saratov
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017

In vivo evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


Clinical application and radiological relavance for Aspergillus fumigatus- and flavus-specific IgG in chronic Pulmonary Aspergillus infection>
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


The contribution of Aspergillus fumigatus to COPD exacerbations: a “sensitive” topic
Source: Eur Respir J, 56 (2) 2002223; 10.1183/13993003.02223-2020
Year: 2020



Performance of Siemens immulite immunoassay for detection of Aspergillus fumigatus and Aspergillus flavus specific IgG for chronic pulmonary aspergillosis diagnosis in Pakistan
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020